Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6216)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2014 (publication date) through May 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng SJ, Liu S, Liu M, McCrae MA, Li JF, Han YP, Xu CH, Ren F, Chen Y, Duan ZP. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2014; 20(9): 2403-2411 [PMID: 24605039 DOI: 10.3748/wjg.v20.i9.2403] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i9/2403.htm |
| Number | Citing Articles |
| 1 |
Yunyun Wang, Chao Chen, Jinjin Qi, Fengtian Wu, Jun Guan, Zhi Chen, Haihong Zhu. Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1844-0
|
| 2 |
O. P. Dudanova, M. E. Shubina, A. S. Rodina, I. V. Kurbatova, L. V. Topchieva. Role of tissue molecular pathogens in development of acute chronic liver failure in alcoholic liver cirrhosis. Medical alphabet 2021; (35): 19 doi: 10.33667/2078-5631-2021-35-19-22
|
| 3 |
Magdalena Świderska, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Magdalena Rogalska-Płońska, Agnieszka Stawicka, Anatol Panasiuk, Robert Flisiak. Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/3480234
|
| 4 |
Oliver Waidmann, Friederike Brunner, Eva Herrmann, Stefan Zeuzem, Albrecht Piiper, Bernd Kronenberger. Cytokeratin 18‐based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients. Liver International 2016; 36(10): 1464 doi: 10.1111/liv.13117
|
| 5 |
Lei Fu, Nurdan Guldiken, Katharina Remih, Anna Sophie Karl, Christian Preisinger, Pavel Strnad. Serum/Plasma Proteome in Non-Malignant Liver Disease. International Journal of Molecular Sciences 2024; 25(4): 2008 doi: 10.3390/ijms25042008
|
| 6 |
Ali Ozgur Ersoy, Ayse Kirbas, Sibel Ozler, Ebru Ersoy, A. Seval Ozgu-Erdinc, Merve Ergin, Salim Erkaya, Dilek Uygur, Nuri Danisman. Maternal and fetal serum levels of caspase-cleaved fragments of cytokeratin-18 in intrahepatic cholestasis of pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 2016; 29(4): 562 doi: 10.3109/14767058.2015.1011116
|
| 7 |
Stewart Macdonald, Fausto Andreola, Patrik Bachtiger, Alex Amoros, Marco Pavesi, Rajeshwar Mookerjee, Yu Bao Zheng, Henning Gronbaek, Alexander L. Gerbes, Elsa Sola, Paolo Caraceni, Richard Moreau, Pere Gines, Vicente Arroyo, Rajiv Jalan. Cell death markers in patients with cirrhosis and acute decompensation. Hepatology 2018; 67(3): 989 doi: 10.1002/hep.29581
|
| 8 |
Zhujun Cao, Liwen Chen, Jing Li, Yuhan Liu, Rebecca Bao, Kehui Liu, Lei Yan, Yezhou Ding, Qing Guo, Xiaogang Xiang, Jingdong Xie, Lanyi Lin, Qing Xie, Shisan Bao, Hui Wang. Serum keratin‐18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus‐related cirrhosis. Journal of Viral Hepatitis 2019; 26(7): 835 doi: 10.1111/jvh.13100
|
| 9 |
Ting Feng, Jun Zhang, Guifang Zeng, Rong Zhou, Xiaohong Tang, Chang Cui, Yongyong Li, Hongwei Wang, Tao Li, Weimin Zhu, Zebo Yu. Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Hepatic Failure. The International Journal of Artificial Organs 2015; 38(5): 271 doi: 10.5301/ijao.5000390
|
| 10 |
Mark J.W. McPhail, Debbie L. Shawcross, Matthew R. Lewis, Iona Coltart, Elizabeth J. Want, Charalambos G. Antoniades, Kiril Veselkov, Evangelos Triantafyllou, Vishal Patel, Oltin Pop, Maria Gomez-Romero, Michael Kyriakides, Rabiya Zia, Robin D. Abeles, Mary M.E. Crossey, Wayel Jassem, John O’Grady, Nigel Heaton, Georg Auzinger, William Bernal, Alberto Quaglia, Muireann Coen, Jeremy K. Nicholson, Julia A. Wendon, Elaine Holmes, Simon D. Taylor-Robinson. Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis. Journal of Hepatology 2016; 64(5): 1058 doi: 10.1016/j.jhep.2016.01.003
|
| 11 |
Guofeng Ding, Zhi Li, Lei Zhang, Hui Ma, Hui Li. Circulating full‐length cytokeratin 18 for predicting prognosis of hepatitis B virus‐related acute‐on‐chronic liver failure patients with lamivudine treatment. Hepatology Research 2016; 46(4): 329 doi: 10.1111/hepr.12549
|
| 12 |
Ayhan Balkan, Nimet Yılmaz, Yasemin Balkan, Irfan Koruk, Mustafa Örkmez, Musa Aydınlı, Mehmet Koruk. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection. Arab Journal of Gastroenterology 2017; 18(2): 98 doi: 10.1016/j.ajg.2017.05.008
|
| 13 |
Takayuki Kondo, Kentaro Fujimoto, Kisako Fujiwara, Sae Yumita, Takamasa Ishino, Keita Ogawa, Miyuki Nakagawa, Terunao Iwanaga, Keisuke Koroki, Hiroaki Kanzaki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Sadahisa Ogasawara, Shingo Nakamoto, Tetsuhiro Chiba, Jun Kato, Keiichi Fujiwara, Naoya Kato. Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-41425-6
|
| 14 |
Gautam Mehta, Sam Rousell, Gary Burgess, Mark Morris, Gavin Wright, Stuart McPherson, Catherine Frenette, Matthew Cave, David T. Hagerty, Alfred Spada, Rajiv Jalan. A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis. Journal of Clinical and Experimental Hepatology 2018; 8(3): 224 doi: 10.1016/j.jceh.2017.11.006
|
| 15 |
MohammadMahdi Saeidinejad, Ahmed Elshabrawi, Supachaya Sriphoosanaphan, Fausto Andreola, Gautam Mehta, Banwari Agarwal, Rajiv Jalan. Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure. Seminars in Liver Disease 2023; 43(04): 429 doi: 10.1055/s-0043-1776773
|
| 16 |
Christine Bernsmeier, Arjuna Singanayagam, Vishal C Patel, Julia Wendon, Charalambos G Antoniades. Immunotherapy in the Treatment and Prevention of Infection in Acute-on-chronic Liver Failure. Immunotherapy 2015; 7(6): 641 doi: 10.2217/imt.15.27
|
| 17 |
Manasa Sagaram, Ranganathan Parthasarathy, Sally L. Condon, Charles F. Closson, Maiying Kong, Melanie L. Schwandt, Loretta L. Jophlin, Wenke Feng, Ashutosh J. Barve, Vatsalya Vatsalya. Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis. International Journal of Molecular Sciences 2022; 23(10): 5852 doi: 10.3390/ijms23105852
|
| 18 |
Yi‐Xiang Zheng, Xiao Zhong, Ya‐Jun Li, Xue‐Gong Fan. Performance of scoring systems to predict mortality of patients with acute‐on‐chronic liver failure: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(10): 1668 doi: 10.1111/jgh.13786
|
| 19 |
Junko Fujihara, Yoshikazu Takinami, Kaori Kimura-Kataoka, Yasuyuki Kawai, Haruo Takeshita. Cell-free DNA Release in the Plasma of Patients with Cardiac Disease is Associated with Cell Death Processes. Indian Journal of Clinical Biochemistry 2023; 38(1): 67 doi: 10.1007/s12291-022-01034-y
|
| 20 |
Nadir Abbas, Neil Rajoriya, Ahmed M Elsharkawy, Abhishek Chauhan. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?. Expert Review of Gastroenterology & Hepatology 2022; 16(7): 639 doi: 10.1080/17474124.2022.2097070
|
| 21 |
Christine Bernsmeier, Oltin T. Pop, Arjuna Singanayagam, Evangelos Triantafyllou, Vishal C. Patel, Christopher J. Weston, Stuart Curbishley, Fouzia Sadiq, Nikhil Vergis, Wafa Khamri, William Bernal, Georg Auzinger, Michael Heneghan, Yun Ma, Wayel Jassem, Nigel D. Heaton, David H. Adams, Alberto Quaglia, Mark R. Thursz, Julia Wendon, Charalambos G. Antoniades. Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK. Gastroenterology 2015; 148(3): 603 doi: 10.1053/j.gastro.2014.11.045
|
| 22 |
Agustín Albillos, Rosa Martin-Mateos, Schalk Van der Merwe, Reiner Wiest, Rajiv Jalan, Melchor Álvarez-Mon. Cirrhosis-associated immune dysfunction. Nature Reviews Gastroenterology & Hepatology 2022; 19(2): 112 doi: 10.1038/s41575-021-00520-7
|
| 23 |
Danielle Adebayo, Vincenzo Morabito, Fausto Andreola, Giulia Pieri, Tu‐Vin Luong, Amar Dhillon, Rajeshwar Mookerjee, Rajiv Jalan. Mechanism of cell death in acute‐on‐chronic liver failure: a clinico‐pathologic‐biomarker study. Liver International 2015; 35(12): 2564 doi: 10.1111/liv.12850
|
| 24 |
Shanze Li, Yuming Wang, Chunyan Li, Na Yang, Hongxin Yu, Wenjie Zhou, Siyu Chen, Shenshen Yang, Yubo Li. Study on Hepatotoxicity of Rhubarb Based on Metabolomics and Network Pharmacology. Drug Design, Development and Therapy 2021; : 1883 doi: 10.2147/DDDT.S301417
|